Feb 27 (Reuters) – Viatris forecast annual revenue and profit below Wall Street estimates on Thursday, two months after the U.S. health regulator restricted imports from one of the drugmaker’s key plants in India. Shares of Viatris fell 14.6% in premarket trading. Viatris in December 23, 2024 disclosed that the U.S. Food and Drug Administration […]
Read More